Stem Cell Dopamine Neurons (Bemdaneprocel)

Type: cell_therapy

Status: FDA Trial. Japan: iPSC leader.

Developer: BlueRock/Bayer

Breakthrough Summary

No summary available.

Mechanism of Action

iPSC-derived dopamine neurons transplanted into brain

Year: 2024-2026